UnitedHealth Group (UNH)

Healthcare · Healthcare Plans · S&P 500
$376.32 -0.60% on the day Market cap $331.6B 52-week range $255.97 to $461.62 Prices as of Oct 7, 2026

What the price implies

A reverse DCF: instead of guessing a fair value, it asks what growth today's price already assumes. How it works.

Free cash flow growth the price needs
5% a year for 10 years

At a market value of $331.6B, UnitedHealth Group's free cash flow of $16.1B (fiscal 2025) would need to grow about 5% a year for the stock to be worth today's price. That is close to what the company has delivered over the last 9 years.

Assumes a 9% discount rate and 3% growth after year 10, on free cash flow (operating cash flow minus capital spending) from UnitedHealth Group's SEC filings. Change any assumption, or model revenue and margins instead, in the Modeling tab, or try your own numbers in the reverse DCF calculator.

Implied by the price5.4% a year
Free cash flow, last 9 years7.9% a year
Revenue, same period10.3% a year
Price to free cash flow20.6x

Fundamental grade

C

Five factors scored 1 to 9 from UNH's latest numbers, weighted into one grade. It describes the business, not whether the stock is a buy.

Valuation6
Profitability4
Growth6
Financial health2
Cash efficiency4

Key numbers

P/E (trailing)27.5x
P/E (forward)20.2x
Price / free cash flow20.6x
EV / EBITDA14.9x
Price / sales0.74x
Price / book3.43x
Revenue growth+0.4%
Operating margin4.8%
Net margin3.1%
Return on equity13.5%
Dividend yield2.4%
Debt / equity1.95x

Results from SEC filings

Fiscal years, from UnitedHealth Group's 10-K filings. The deep dive has 15+ years, quarters and every line.

Fiscal year20212022202320242025
Revenue$287.6B$324.2B$371.6B$400.3B$447.6B
Net income$17.3B$20.1B$22.4B$14.4B$12.1B
Free cash flow$19.9B$23.4B$25.7B$20.7B$16.1B
EPS (diluted)$18.08$21.18$23.86$15.51$13.23
Operating margin8.3%8.8%8.7%8.1%4.2%

Where the revenue comes from

Revenue by segments, fiscal 2025.

UnitedHealthcare$344.9B56%
Optum Rx$154.7B25%
Optum Health$102.0B16%
Optum Insight$19.4B3%

Superinvestors who own UNH

From each investor's latest 13F filing (what a 13F shows). 21 of the investors we track hold it.

InvestorLast quarterValue% of portfolioQuarter
Dodge & Cox
Dodge & Cox
Trimmed $3.8B2.0%Q2 2026
Boykin Curry
Eagle Capital Management
Trimmed $2.4B7.3%Q2 2026
Cliff Asness
AQR Capital Management
Added $729M0.25%Q2 2026
Tom Steyer
Farallon Capital Management LLC
Trimmed $528M2.5%Q2 2026
Hersh Cohen
ClearBridge Investments
Trimmed $313M0.26%Q2 2026
Ruane, Cunniff & Goldfarb
Ruane, Cunniff & Goldfarb
Trimmed $293M4.6%Q2 2026
Charles Brandes
Brandes Investment Partners, LP
Trimmed $176M1.2%Q2 2026
Bill Smead
Smead Capital Management
Trimmed $136M2.9%Q2 2026
Chase Coleman
Tiger Global Management
Trimmed $124M0.52%Q2 2026
Donald Yacktman
Yacktman Asset Management
Added $71M0.88%Q2 2026
PRIMECAP Management
PRIMECAP Management Co
Trimmed $60M0.04%Q2 2026
Joel Greenblatt
Gotham Asset Management
Trimmed $36M0.08%Q2 2026

Insider buying

Open-market purchases by UnitedHealth Group's executives and directors in the last 12 months, from SEC Form 4 filings. What insider buying tells you.

DateInsiderSharesPriceValue
Mar 23, 2026 Ro Khanna
0$269.62—
Mar 23, 2026 Ro Khanna
0$269.62—
Mar 19, 2026 Richard Mccormick
0$280.35—
Mar 19, 2026 Richard Mccormick
0$280.35—
Mar 13, 2026 Gilbert Ray Cisneros, Jr.
0$282.02—
Mar 13, 2026 Gilbert Ray Cisneros, Jr.
0$282.02—
Mar 10, 2026 Ro Khanna
0$282.23—
Mar 10, 2026 Ro Khanna
0$282.23—
Feb 25, 2026 Markwayne Mullin
0$284.11—
Feb 25, 2026 Markwayne Mullin
0$284.11—

Get an alert at your buy price

Pick the price you'd be interested at. We'll email you when UNH trades at or below it.

$

Free accounts get 3 price alerts. No card needed.

In the full deep dive

DCF fair value per share
Yearly return (IRR) at today's price
Growth implied by revenue and margins
15+ years of statements and quarters

Questions

What growth does UnitedHealth Group's stock price imply?

At a market value of $331.6B, UnitedHealth Group would need its free cash flow to grow about 5% a year for 10 years (discounted at 9%, 3% growth after that) to be worth today's price. Over the last 9 years its free cash flow grew 8% a year.

Are UnitedHealth Group insiders buying the stock?

10 open-market insider purchases of UNH in the last 12 months, from SEC Form 4 filings.

Which superinvestors own UnitedHealth Group?

21 of the superinvestors Investingly tracks hold UNH in their latest 13F, including Dodge & Cox, Boykin Curry, Cliff Asness.

Prices and ratios as of Oct 7, 2026; statements from SEC filings. Information only, not investment advice. Superinvestor holdings come from 13F filings, which are filed up to 45 days after each quarter ends.